Abstract
Introduction
Despite formal definitions of mucinous cystic neoplasms (MCNs) and intraductal papillary neoplasms (IPMNs) by the World Health Organization (WHO) and Armed Forces Institute of Pathology (AFIP), several controversies with regard to MCNs remain. The aim of this review was to determine the clinicopathological features of MCNs defined by ovarian-type stroma (OS) as proposed by the WHO and AFIP and to compare them with MCNs defined by less stringent criteria.
Methods
A MEDLINE search was conducted to identify English-language articles on pancreatic MCNs from 1996 to 2005. Twenty-five studies were identified. The studies were divided into 2 groups: group A included 10 studies with 344 patients whereby the presence of OS was a criteria for the diagnosis of MCNs, and group B, included 15 studies comprising 761 patients whereby the presence of OS was not mandatory for the diagnosis of MCNs.
Results
Patients in group A (MCNs as defined by OS) were almost always female (99.7%), with a mean age of 47 (range, 18–95) years. MCNs were located predominantly in the body or tail of the pancreas (94.6%) and had a mean size of 8.7 cm (range, 0.6–35 cm); 76% were symptomatic, 6.8% demonstrated ductal communication, and 27% were malignant. At a mean follow-up of 57.5 (range, 1–264) months and 43 (range, 2–257) months after surgery, 97.9% of benign and 61.9% of malignant neoplasms were disease free, respectively. Patients in group B were older and had a higher proportion of males. Neoplasms were more evenly distributed in the pancreas, were smaller, communicated more frequently with the pancreatic duct, and were composed of a higher proportion of malignant tumors compared with group A. Their clinicopathological features were intermediate between those of group A and patients with IPMN.
Conclusion
Pancreatic MCNs with OS have unique and distinct clinicopathological features. MCNs should be defined by the presence of OS, as it is the most reliable way of distinguishing MCNs from IPMN. Adoption of “looser” criteria will result in misclassification of some IPMNs as MCNs.
Similar content being viewed by others
References
Compagno J, Oertel JE. Microcystic adenomas of the pancreas. Glycogen-rich cystadenomas. Am J Clin Pathol 1978;69:281–298
Compagno J, Oertel JE. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol 1978;69:573–580
Kloppel G, Solcia E, Longnecker DS, et al. World Health Organization international classification of tumours. Histological typing of tumors of the exocrine pancreas. 2nd edn. Springer, Berlin Heidelberg New York, 1996:1–61
Solcia E, Capella C, Kloppel G. Tumors of the pancreas. In: Rosai J, Sobin LH, editors. Atlas of Tumor Pathology. Fascicle 20. 3rd Series. Armed Forces Institute of Pathology, Washington, DC, 1997
Goh BK, Tan YM, Cheow PC, et al. Cystic neoplasms of the pancreas with mucin–production. Eur J Surg Oncol 2005;31:282–287
Fukushima N, Mukai K, Kanai Y, et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. Hum Pathol 1997;28:1010–1017
Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathologic feature, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999;23:410–422
Thompson LD, Becker RC, Przygodzki RM, et al. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low–grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am J Surg Pathol 1999;23:1–16
Shimizu Y, Yasui K, Yamao K, et al. Possible oncogenesis of mucinous cystic tumors of the pancreas lacking ovarian-like stroma. Pancreatology 2002;2:413–420
Hara T, Kawashima H, Ishigooka M, et al. Mucinous cystic tumors of the pancreas. Surg Today 2002;32:965–969
Izumo A, Yamaguchi K, Eguchi T, et al. Mucinous cystic tumor of the pancreas: immunohistochemical assessment of ‚ovarian-type stroma’. Oncol Rep 2003;10:515–525
Kosmahl M, Pauser U, Peters K, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 2004;445:168–178
Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastro Hepatol 2004;2:1026–1031
Sawai H, Okada Y, Funahashi H, et al. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas. Scand J Gastroenterol 2004;11:1159–1165
Yeh MM, Tang LH, Wang S, et al. Inhibin expression in ovarian-type stroma in mucinous cystic neoplasms of the pancreas. Appl Immunohistochem Mol Morphol 2004;12:148–152
Shyr YM, Su CH, Tsay SH, Lui WY. Mucin-producing neoplasms of the pancreas: intraductal papillary and mucinous cystic neoplasms. Ann Surg 1996;223:141–146
Sugiyama M, Atomi Y, Kuroda A. Two types of mucin-producing cystic tumors of the pancreas: diagnosis and treatment. Surgery 1997;122:617–625
Wilentz RE, Albores-Saavedra J, Zahurak M, et al. Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 1999;23(11):1320–1327
Le Borgne J, de Calam L, Partensky C. The French Surgical Association. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstituitional retrospective study of 398 cases. Ann Surg 1999;23:152–161
Scott J, Martin I, Redhead D, et al. Mucinous cystic neoplasms of the pancreas: imaging features and diagnostic difficulties. Clin Radiol 2000;55:187–192
Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas. Can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 2000;231(2):205–212
Shima Y, Mori M, Takakura N, et al. Diagnosis and management of cystic pancreatic tumours with mucin production. Br J Surg 2000;87:1041–1047
Yamaguchi K, Yokohata K, Noshiro H, et al. Mucinous cystic neoplasm of the pancreas or intraductal papillary mucinous tumor of the pancreas. Eur J Surg 2000;166:141–148
Fujino Y, Suzuki Y, Ajiki T, et al. Surgical treatment for mucin-producing tumors of the pancreas. Hepatogastroenterology 2001;48:1157–1161
Yeh TS, Jan YY, Chiu CT, et al. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal carcinoma. Gut 2002;51:712–726
Kim SG, Wu TT, Lee JH, et al. Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. Mod Pathol 2003;16:1086–1094
Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas. A Japanese multiinsitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004;28 (3):241–246
Warshaw AL, Compton CC, Lewandrowski K, et al. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 1990;212:432–445
Angelica D’ M, Brennan MF, Suriawinata AA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 2004;239:400–408
Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678–685
Sohn TA, Yeo CJ, Cmaeron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004;239:788–797
Wada K, Korazek RA, Traverso WL. Outcome following resection of invasive and non-invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 2005;189:632–636
Jang JY, Kim SW, Ahn YJ, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005;12:124-132
Sugiyama M, Atomi Y. Recent topics in mucinous cystic tumor and intraductal papillary mucinous tumor of the pancreas. J Hepato Pancreat Surg 2003;10:123–124
Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17–32
Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma in the liver and bile ducts. Cancer 1985;56:1434–1445
Gui L, Bigler SA, Subramony C. Lymphangioma of the pancreas with “ovarian-like” mesenchymal stroma. Arch Pathol Lab Med 2003;127:1513–1516
Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma: a light microscope and immunohistochemical study of 70 cases. Am J Surg Pathol 1994;18:1078–1091
Wenig B, Albores-Saavedra J, Buetow PC, et al. Pancreatic mucinous neoplasm with sarcomatous stroma. A report of three cases. Am J Surg Pathol 1997;21 (1):70–80
Suyama Y, Horte Y, Suou T. Oral contraceptives and intrahepatic biliary cystadenoma having an increased level of estrogen receptor. Hepatogastroenterologica 1988 ;35:171–174
Suzuki M, Fujita N, Onodera H, et al. Mucinous cystic neoplasm in a young male patient. J Gastroenterol 2005;40:1070-1074
Goh BK, Tan YM, Kumarasinghe MP, et al. Mucinous cystic tumor of the pancreas with ovarian-like mesenchymal stroma in a male patient. Dig Dis Sci 2005;50:2170–2177
Wouters K, Extors N, Van Steenbergen W, et al. A pancreatic mucinous cystadenoma in a man with mesenchymal stroma, expressing oestrogen and progesterone receptors. Virchows Arch 1998;432:187–189
Yamao K, Nakamura T, Suzuki T, et al. Endoscopic diagnosis and staging of mucinous cystic neoplasms and intraductal papillary mucinous tumors. J Hepatobiliary Pancreat Surg 2003;10:142–146
Wilentz RE, Albores-Saavedra J, Hruban RH. Mucinous cystic neoplasms of the pancreas. Semin Diagn Pathol 2000;17:31–42
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented in part at the 7th World Congress of the International Hepato-Pancreato-Biliary Association, Edinburgh, 3-7 Sept 2006 (oral presentation)
Rights and permissions
About this article
Cite this article
Goh, B.K.P., Tan, YM., Chung, YF.A. et al. A Review of Mucinous Cystic Neoplasms of the Pancreas Defined by Ovarian-type Stroma: Clinicopathological Features of 344 Patients. World J. Surg. 30, 2236–2245 (2006). https://doi.org/10.1007/s00268-006-0126-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-006-0126-1